Biotech Acquisition Co - Warrants (30/11/2027)'s net tangible assets is $-13M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Biotech Acquisition Co - Warrants (30/11/2027) (BIOTW) currently reports a net tangible assets of $-13M as of September 2022. That compares with $210M in the prior-year period — down 106.2% year over year. Use the charts on this page to explore Biotech Acquisition Co - Warrants (30/11/2027)'s net tangible assets history and peer comparisons.
Biotech Acquisition Co - Warrants (30/11/2027)'s net tangible assets decreased from $210M to $-13M — a 106.2% year-over-year decrease (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Biotech Acquisition Co - Warrants (30/11/2027) reported $-13M in net tangible assets as of September 2022. That compares with $210M in the prior-year period — down 106.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current net tangible assets of $-13M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Biotech Acquisition Co - Warrants (30/11/2027), and consider following BIOTW for alerts when major investors trade the stock.